A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas
HAEMATOLOGICA (2021)
Journal
HAEMATOLOGICA
Volume 106, Issue 8, Pages 2277-2280Publisher
FERRATA STORTI FOUNDATION
Keywords
Categories
Funding
- Takeda Pharmaceuticals Co, Ltd.
- Korean Health Technology R&D Project Strategic Center of Cell and Bio Therapy for Heart, Diabetes & Cancer through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare (MHW) [HI-17C-2085]
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb
Yang Wu, Dan Chen, Ya Lu, Shu-Chen Dong, Rong Ma, Wei-yan Tang, Jian-qiu Wu, Ji-Feng Feng, Jian-Zhong Wu
CANCER GENE THERAPY (2022)
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+lymphomas
Nicholas P. Tschernia, Hillary Heiling, Allison M. Deal, Catherine Cheng, Caroline Babinec, Megan Gonzalez, J. Kaitlin Morrison, Christopher Dittus, Gianpietro Dotti, Anne W. Beaven, Jonathan S. Serody, William A. Wood, Barbara Savoldo, Natalie S. Grover
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)
Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions
John C. Reneau, Polina Shindiapina, Zachary Braunstein, Youssef Youssef, Miguel Ruiz, Saira Farid, Walter Hanel, Jonathan E. Brammer
JOURNAL OF CLINICAL MEDICINE (2022)
Advances in CD30-and PD-1-targeted therapies for relapsed or refractory Hodgkin lymphoma
Huimin Ma, Xin Li, Meng Lin, Kebing Lv, Mingzhi Zhang, Xiaolong Wu
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH (2021)
Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study
Christian Rausch, Ulrike Bacher, Manuela Rabaglio, Corinne Vorburger, Anke Klingenberg, Yara Banz, Michael Daskalakis, Thomas Pabst
JOURNAL OF CLINICAL MEDICINE (2022)
Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?
Selma Addou, Clementine Sarkozy, Julien Lazarovici, Stephane Champiat, Aspasia Stamatoullas, Fabrice Jardin, Vincent Ribrag, Aurelien Marabelle, Jean-Marie Michot
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond
Salvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, Ilenia Iamundo De Cumis, Alessandro Pulsoni, Paolo Strati
CANCERS (2023)
CD30 as a therapeutic target in adult haematological malignancies: Where are we now?
M. Veyri, J. P. Spano, F. Le Bras, A. G. Marcelin, E. Todesco
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review
Yujie Zhang, Zhichao Xing, Li Mi, Zhihui Li, Jingqiang Zhu, Tao Wei, Wenshuang Wu
FRONTIERS IN ONCOLOGY (2022)
Clinical and Therapeutic Implications of Epstein-Barr Virus in HIV-Related Lymphomas
Miriam Verdu-Bou, Gustavo Tapia, Agueda Hernandez-Rodriguez, Jose-Tomas Navarro
CANCERS (2021)
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
Ryan Ashkar, Darren R. Feldman, Nabil Adra, Mohammad Abu Zaid, Samuel A. Funt, Sandra K. Althouse, Susan M. Perkins, Christin I. Snow, Kayla M. Lazzara, Lina M. Sego, David I. Quinn, Nasser H. Hanna, Lawrence H. Einhorn, Costantine Albany
INVESTIGATIONAL NEW DRUGS (2021)
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma
Sanjal H. Desai, Michael A. Spinner, Kevin David, Veronika Bachanova, Gaurav Goyal, Brad Kahl, Kathleen Dorritie, Jacques Azzi, Vaishalee P. Kenkre, Sally Arai, Cheryl Chang, Brendon Fusco, Nuttavut Sumransub, Haris Hatic, Raya Saba, Uroosa Ibrahim, Elyse Harris, Harsh Shah, Jacob Murphy, Stephen Ansell, Deepa Jagadish, Victor Orellana-noia, Catherine Diefenbach, Siddharth Iyenger, K. C. Rappazzo, Rahul Mishra, Yun Choi, Grzegorz S. Nowakowski, Ranjana H. Advani, Ivana N. Micallef
AMERICAN JOURNAL OF HEMATOLOGY (2023)
Prospective evaluation of blood Epstein-Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas
Julien Lupo, Raphaele Germi, Remi Lancar, Michele Algarte-Genin, Houria Hendel-Chavez, Yassine Taoufik, Nicolas Mounier, Marialuisa Partisani, Fabrice Bonnet, Marie-Caroline Meyohas, Bruno Marchou, Anastasiia Filippova, Sophie Prevot, Dominique Costagliola, Patrice Morand, Caroline Besson
AIDS (2021)
Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas
Emmanuela N. Bonglack, Joshua E. Messinger, Jana M. Cable, James Ch'ng, K. Mark Parnell, Nicolas M. Reinoso-Vizcaino, Ashley P. Barry, Veronica S. Russell, Sandeep S. Dave, Heather R. Christofk, Micah A. Luftig
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas
Leon D. Kaulen, Evgeniya Denisova, Felix Hinz, Ling Hai, Dennis Friedel, Octavian Henegariu, Dirk C. Hoffmann, Jakob Ito, Alexandros Kourtesakis, Pascal Lehnert, Sofia Doubrovinskaia, Philipp Karschnia, Louisa von Baumgarten, Tobias Kessler, Joachim M. Baehring, Benedikt Brors, Felix Sahm, Wolfgang Wick
ACTA NEUROPATHOLOGICA (2023)
Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
Hyerim Ha, Bhumsuk Keam, Chan-Young Ock, Tae Min Kim, Jin Ho Kim, Eun-Jae Chung, Seong Keun Kwon, Soon-Hyun Ahn, Hong-Gyun Wu, Myung-Whun Sung, Dae Seog Heo
KOREAN JOURNAL OF INTERNAL MEDICINE (2021)
Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
Chang Hyun Nam, Jaemoon Koh, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo
KOREAN JOURNAL OF INTERNAL MEDICINE (2021)
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy
Changhee Park, Kyeonghun Jeong, Joon-Hyeong Park, Sohee Jung, Jeong Mo Bae, Kwangsoo Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Ju-Seog Lee, Dong-Wan Kim, Gyeong Hoon Kang, Doo Hyun Chung, Dae Seog Heo
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea
Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim
CANCER RESEARCH AND TREATMENT (2022)
Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non-Small Cell Lung Cancer
Chaelin Lee, Miso Kim, Dong-Wan Kim, Tae Min Kim, Soyeon Kim, Sun-Wha Im, Yoon Kyung Jeon, Bhumsuk Keam, Ja-Lok Ku, Dae Seog Heo
CANCER RESEARCH AND TREATMENT (2022)
Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab
Jun Won Park, Jeffrey R. Curtis, Kang Il Jun, Tae Min Kim, Dae Seog Heo, Jongwon Ha, Kyung-Suk Suh, Kwang-Woong Lee, Hajeong Lee, Jaeseok Yang, Min Jung Kim, Yunhee Choi, Eun Bong Lee
CHEST (2022)
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
So Yeon Oh, Soyeon Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
SCIENTIFIC REPORTS (2021)
Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
Ha-Ram Park, Seong-Eun Kim, Bhumsuk Keam, Hyewon Chung, Seung Hyeok Seok, Soyeon Kim, Miso Kim, Tae Min Kim, Junsang Doh, Dong-Wan Kim, Dae Seog Heo
SCIENTIFIC REPORTS (2022)
Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea
Jung Sun Kim, Sun Young Lee, Min Sung Lee, Shin Hye Yoo, Jeongmi Shin, Wonho Choi, Yejin Kim, Hyung Sook Han, Jinui Hong, Bhumsuk Keam, Dae Seog Heo
BMC PALLIATIVE CARE (2022)
The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study
Jeong-Han Kim, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)
Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines
Jeongjae Lee, Bhumsuk Keam, Ha-Ram Park, Ji-Eun Park, Soyeon Kim, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)
The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines
Jeongjae Lee, Bhumsuk Keam, Soyeon Kim, Jung-Nyoung Heo, Eunkyo Joung, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
TRANSLATIONAL ONCOLOGY (2023)
Treatment strategies based on the molecular subtypes of transformed small cell lung cancer (t-SCLC)
S. Oh, J. Koh, T. M. Kim, S. Kim, J. Youk, M. Kim, B. Keam, Y. K. Jeon, D. W. Kim, D. S. Heo
EUROPEAN JOURNAL OF CANCER (2022)
Mechanisms of resistance to mobocertinib in EGFR exon 20 insertion-mutant non-small cell lung cancer (NSCLC)
S. Park, T. M. Kim, S. Kim, M. Kim, B. Keam, D. W. Kim, D. S. Heo
EUROPEAN JOURNAL OF CANCER (2022)
Exploring the Way for Respecting the Patient's Autonomy Under the Law of the Life-Sustaining Treatment Decision Act in Korea
Do Yeun Kim, Dal-Yong Kim, Shin Hye Yoo, Min Sun Kim, Seyoung Seo, Sung Joon Shin, Chiyeon Lim, Dae Seog Heo, Chae-Man Lim
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2021)